Posts by Hayley Sotolotto
Regulatory Status of Homeopathy in the EU & UK: What’s Happened Since Brexit?
By Steve Mann, Director of External Regulatory Affairs, Nelsons To say the world has changed over the last couple of years might just be the understatement of the century…
Read MoreRegulation of Homeopathic Medicines in Canada
Submitted by David Skinner, Canadian Homeopathic Pharmaceutical Association Homeopathic medicines (HMs) are regulated in Canada by Health Canada, the federal government department responsible for ensuring the safety, efficacy, and…
Read MoreThe Regulation of Homeopathic Medicines in 2022
By Mark Land, AAHP President The content in our June 2022 newsletter on regulation turned out quite different than I imagined when we discussed it at an editorial planning…
Read MoreFDA Seeks Accelerated Drug Approval, DSHEA, Cosmetics Legislative Reforms
By Pete Evich, AAHP Government Relations As part of the President’s FY 2023 Budget proposal, FDA has called upon Congress to take up legislation that would give the agency additional…
Read MoreRecent HPCUS Meetings and Updates
By Eric Foxman, Pharm. (Ret.), AAHP Secretary The Homeopathic Pharmacopoeia Convention of the United States held its annual meeting in the latter half of April. This included both the Board…
Read MoreThe Homeopathic Pharmacopoeia Convention of the United States Continues to Play a Vital Role
By Mark Land, AAHP President The first edition of the Homeopathic Pharmacopoeia of the United States (HPUS) was first published in 1897 — 125 years ago! Since FDA’s 2019 draft…
Read More